WallachBeth Starts Orexigen (OREX) at Buy; Sees Contrave With Edge Over Peers (ARNA) (VVUS)
Tweet Send to a Friend
WallachBeth initiates Orexigen Therapeutics (Nasdaq: OREX) with a Buy rating and $9 price target.
Analyst Bob Ai sees FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst Bob Ai sees FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
